Moderna to supply 12 million bivalent doses targeting Omicron variant
Moderna will supply 12 million doses of its bivalent COVID-19 vaccine targeting the Omicron variant to Canada, with regulatory review underway and delivery scheduled for 2022.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthModerna to supply 12 million bivalent doses targeting Omicron variant
Sign in or subscribeBrowse free archive reportsModerna will supply 12 million doses of its bivalent COVID-19 vaccine targeting the Omicron variant to Canada, with regulatory review underway and delivery scheduled for 2022.